more

Labcorp (LH)

(Delayed Data from NYSE)

$234.38 USD

+5.27 (2.30%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $234.35 -0.03 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Zacks News

LabCorp (LH) Looks Good: Stock Adds 9% in Session

by Zacks Equity Research Published on April 28,2020

LabCorp (LH) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

medical

3 Medical Product Stocks Set to Beat This Earnings Season

by Urmimala Biswas Published on April 24,2020

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

The Zacks Analyst Blog Highlights: PayPal, International Business Machines, Fresenius Medical Care, Laboratory Corp. of America and Insulet

by Zacks Equity Research Published on April 23,2020

The Zacks Analyst Blog Highlights: PayPal, International Business Machines, Fresenius Medical Care, Laboratory Corp. of America and Insulet

Earnings Preview: LabCorp (LH) Q1 Earnings Expected to Decline

by Zacks Equity Research Published on April 22,2020

LabCorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LHPositive Net Change

Economic Data Deluge

by Zacks Equity Research Published on April 22,2020

Economic Data Deluge

Crude Oil Rebounds, New COVID Tests & Q1 Earnings

by Mark Vickery Published on April 22,2020

The Dow looks to open up around 400 points, with the Nasdaq +175 and the S&P 500 +50. The Dow had lost over 1100 points total in the first two trading sessions this week.

Top Stock Reports for PayPal, IBM & Fresenius Medical

by Sheraz Mian Published on April 22,2020

Today's Research Daily features new research reports on 16 major stocks, including PayPal (PYPL), International Business Machines (IBM) and Fresenius Medical Care (FMS).

Will LabCorp's (LH) Coronavirus Test Boost Q1 Earnings?

by Zacks Equity Research Published on April 21,2020

LabCorp (LH) is expected to have witnessed a significant fall in its quarterly revenues due to the coronavirus mayhem.

earnings

3 Stocks Testing The Coronavirus

by Daniel Laboe Published on March 30,2020

If we can test the working population, we will be able to bring the healthy American's back to work and isolate those with the virus

Here's Why You Should Hold on to LabCorp (LH) Stock for Now

by Zacks Equity Research Published on March 27,2020

Investors continue to be optimistic about LabCorp (LH) on its strong segmental results in the fourth quarter of 2019.

medical

Bruker Inks Deal to Distribute Coronavirus Detection Test

by Zacks Equity Research Published on March 26,2020

The agreement would make Bruker (BRKR) a key player in coronavirus diagnosis.

New Buyouts & Envigo Deal Aid LabCorp Amid Regulatory Woes

by Zacks Equity Research Published on March 25,2020

LabCorp's (LH) Covance arm grows on strategic acquisitions including MI Bioresearch.

medical

LabCorp Aims to Prioritize Inpatient Coronavirus Testing

by Debanjana Dey Published on March 24,2020

LabCorp (LH) aims to serve the hospital inpatient population, with guidance provided by the CDC. It is also preparing to support faster point-of-care testing in hospitals.

medical

Tech Giants Boost Efforts to Deal With Coronavirus Crisis

by Radhika Pujara Published on March 24,2020

Here we discuss how tech giants including Microsoft (MSFT) and others are leaving no stone unturned to address COVID-19 crisis in innovative ways, backed by AI, ML and cloud computing capabilities.

Microsoft, Adaptive Biotech Collaborate to Fight COVID-19

by Zacks Equity Research Published on March 23,2020

Microsoft (MSFT) extends partnership with Adaptive Biotechnologies on an open source dataset to aid the development of a diagnostic vaccine for COVID-19.

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

by Zacks Equity Research Published on March 19,2020

Style Box ETF report for DEF

4 Potential Gainers Amid Intensifying Coronavirus Fears

by Trina Mukherjee Published on March 19,2020

Amid the pandemonium associated with coronavirus, we look into four stocks that have the potential to benefit from this outbreak.

medical

QIAGEN Gets CE Nod for QIAstat-Dx Respiratory SARS-CoV-2 Test

by Zacks Equity Research Published on March 19,2020

The regulatory clearance of this test has made QIAGEN (QGEN) a key player in coronavirus diagnosis.

medical

Coronavirus Testing Players Gain Momentum: 3 Stocks in Focus

by Sriparna Ghosal Published on March 18,2020

There are several key diagnostic testing laboratory and biotech players whose prospects seem bright on account of rigorous work on developing diagnostic testing for the coronavirus.